Thalidomide is classified as an immunomodulatory agent, which means it affects the levels of certain chemicals in the body that control the activity of cells.
Celgene's Patient Support Coordinators assist patients and healthcare providers to navigate the challenges of reimbursement, provide information about co-pay assistance, and answer general questions about Revlimid.